home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development Summit
Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development Summit
Post navigation
Previous Post
Previous
Kronos Bio Appoints Marni Kottle as Senior Vice President of Corporate Communications and Investor Relations
Next Post
Next
EQRx Announces Presentation of Phase 3 Data Demonstrating a Progression-Free Survival Benefit with Sugemalimab Consolidation Therapy in Patients with Stage III NSCLC at ESMO Congress 2021